2022 Q4 Form 10-Q Financial Statement
#000149315222032059 Filed on November 14, 2022
Income Statement
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
Revenue | $159.0K | $134.0K | $23.00K |
YoY Change | 140.91% | 482.61% | 91.67% |
Cost Of Revenue | $352.0K | $430.0K | $211.0K |
YoY Change | 22.65% | 103.79% | 37.91% |
Gross Profit | -$193.0K | -$296.0K | -$188.0K |
YoY Change | -12.67% | 57.45% | 33.33% |
Gross Profit Margin | -121.38% | -220.9% | -817.39% |
Selling, General & Admin | $397.0K | $981.0K | $1.782M |
YoY Change | -80.01% | -44.95% | 139.84% |
% of Gross Profit | |||
Research & Development | $1.174M | $1.048M | $596.0K |
YoY Change | 80.06% | 75.84% | 313.89% |
% of Gross Profit | |||
Depreciation & Amortization | $91.00K | $57.00K | $24.00K |
YoY Change | 78.43% | 137.5% | 0.0% |
% of Gross Profit | |||
Operating Expenses | $1.564M | $2.029M | $2.375M |
YoY Change | -40.6% | -14.57% | 167.76% |
Operating Profit | -$1.757M | -$2.325M | -$2.563M |
YoY Change | -38.44% | -9.29% | 149.32% |
Interest Expense | $93.00K | $73.00K | $1.000K |
YoY Change | -24.39% | 7200.0% | 0.0% |
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | -$1.664M | -$2.244M | -$2.562M |
YoY Change | -39.07% | -12.41% | 149.46% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$1.664M | -$2.244M | -$2.562M |
YoY Change | -39.07% | -12.41% | 149.46% |
Net Earnings / Revenue | -1046.54% | -1674.63% | -11139.13% |
Basic Earnings Per Share | -$0.32 | -$0.37 | |
Diluted Earnings Per Share | -$0.23 | -$315.1K | -$369.7K |
COMMON SHARES | |||
Basic Shares Outstanding | 7.122M shares | 7.122M shares | 6.930M shares |
Diluted Shares Outstanding | 7.122M shares |
Balance Sheet
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $13.15M | $15.17M | $19.73M |
YoY Change | -32.91% | -23.12% | 526.19% |
Cash & Equivalents | $10.10M | $2.586M | $19.73M |
Short-Term Investments | $3.047M | $12.58M | |
Other Short-Term Assets | $281.0K | $272.0K | $537.0K |
YoY Change | -36.57% | -49.35% | 93.86% |
Inventory | $630.0K | $652.0K | $145.0K |
Prepaid Expenses | |||
Receivables | $60.00K | $15.00K | $19.00K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $14.12M | $16.10M | $20.43M |
YoY Change | -30.16% | -21.16% | 313.48% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $648.0K | $708.0K | $1.126M |
YoY Change | -17.03% | -37.12% | 205.15% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $328.0K | $325.0K | $416.0K |
YoY Change | -17.17% | -21.88% | 27.22% |
Total Long-Term Assets | $2.778M | $2.913M | $3.176M |
YoY Change | -16.68% | -8.28% | 356.32% |
TOTAL ASSETS | |||
Total Short-Term Assets | $14.12M | $16.10M | $20.43M |
Total Long-Term Assets | $2.778M | $2.913M | $3.176M |
Total Assets | $16.90M | $19.02M | $23.60M |
YoY Change | -28.25% | -19.43% | 318.77% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $297.0K | $366.0K | $201.0K |
YoY Change | 188.35% | 82.09% | 11.05% |
Accrued Expenses | $778.0K | $694.0K | $880.0K |
YoY Change | -5.24% | -21.14% | 49.41% |
Deferred Revenue | $1.426M | $1.429M | |
YoY Change | 312.14% | ||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $2.559M | $2.556M | $1.106M |
YoY Change | 95.49% | 131.1% | -43.89% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $2.550M | $2.733M | $1.894M |
YoY Change | -2.71% | 44.3% | 436.54% |
Total Long-Term Liabilities | $2.550M | $2.733M | $1.894M |
YoY Change | -2.71% | 44.3% | 436.54% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.559M | $2.556M | $1.106M |
Total Long-Term Liabilities | $2.550M | $2.733M | $1.894M |
Total Liabilities | $5.109M | $5.289M | $3.000M |
YoY Change | 30.0% | 76.3% | 29.09% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$24.76M | -$23.10M | |
YoY Change | 61.91% | ||
Common Stock | $36.55M | $36.83M | |
YoY Change | 4.69% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $11.79M | $13.73M | $20.60M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $16.90M | $19.02M | $23.60M |
YoY Change | -28.25% | -19.43% | 318.77% |
Cashflow Statement
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.664M | -$2.244M | -$2.562M |
YoY Change | -39.07% | -12.41% | 149.46% |
Depreciation, Depletion And Amortization | $91.00K | $57.00K | $24.00K |
YoY Change | 78.43% | 137.5% | 0.0% |
Cash From Operating Activities | -$1.988M | -$1.709M | -$1.650M |
YoY Change | 68.19% | 3.58% | 281.06% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $31.00K | $45.00K | -$313.0K |
YoY Change | -127.68% | -114.38% | 1017.86% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $9.500M | -$3.000M | |
YoY Change | -186.36% | ||
Cash From Investing Activities | $9.469M | -$3.045M | -$313.0K |
YoY Change | -185.21% | 872.84% | 1017.86% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | -95.00K | |
YoY Change | -100.0% | ||
NET CHANGE | |||
Cash From Operating Activities | -1.988M | -$1.709M | -1.650M |
Cash From Investing Activities | 9.469M | -$3.045M | -313.0K |
Cash From Financing Activities | 0.000 | -95.00K | |
Net Change In Cash | 7.481M | -$4.754M | -2.058M |
YoY Change | -166.43% | 131.0% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.988M | -$1.709M | -$1.650M |
Capital Expenditures | $31.00K | $45.00K | -$313.0K |
Free Cash Flow | -$2.019M | -$1.754M | -$1.337M |
YoY Change | 88.69% | 31.19% | 230.12% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001577445 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
SCTC |
Round Up Shares Due To Reverse Stock Split
RoundUpSharesDueToReverseStockSplit
|
usd | ||
CY2022Q3 | us-gaap |
Severance Costs1
SeveranceCosts1
|
usd | |
CY2021Q3 | us-gaap |
Severance Costs1
SeveranceCosts1
|
usd | |
SCTC |
Gain Or Loss On Exchange From Operating Lease Liability
GainOrLossOnExchangeFromOperatingLeaseLiability
|
usd | ||
CY2021Q3 | SCTC |
Gain Or Loss On Exchange From Operating Lease Liability
GainOrLossOnExchangeFromOperatingLeaseLiability
|
usd | |
SCTC |
Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
|
usd | ||
CY2021Q3 | SCTC |
Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
|
usd | |
CY2021Q3 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
usd | |
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
usd | ||
CY2021Q3 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
usd | |
SCTC |
Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
|
usd | ||
CY2021Q3 | SCTC |
Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
|
usd | |
SCTC |
Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
|
usd | ||
CY2022Q3 | SCTC |
Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
|
usd | |
CY2021Q3 | SCTC |
Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
|
usd | |
SCTC |
Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
|
usd | ||
CY2021Q3 | SCTC |
Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
|
usd | |
SCTC |
Issuance Expenses
IssuanceExpenses
|
usd | ||
CY2022Q3 | SCTC |
Issuance Expenses
IssuanceExpenses
|
usd | |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
usd | ||
CY2022Q3 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
usd | |
CY2021Q3 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
usd | |
SCTC |
Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
|
usd | ||
CY2022Q3 | SCTC |
Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
|
usd | |
CY2021Q3 | SCTC |
Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
|
usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | ||
CY2022Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | |
SCTC |
Non Cash Issuance Expenses
NonCashIssuanceExpenses
|
usd | ||
CY2022Q3 | SCTC |
Non Cash Issuance Expenses
NonCashIssuanceExpenses
|
usd | |
CY2021Q3 | SCTC |
Non Cash Issuance Expenses
NonCashIssuanceExpenses
|
usd | |
SCTC |
Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
|
usd | ||
CY2021Q3 | SCTC |
Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
|
usd | |
SCTC |
Noncash Related To Increase In Property And Equipment Through A Decrease In Advances To Suppliers
NoncashRelatedToIncreaseInPropertyAndEquipmentThroughADecreaseInAdvancesToSuppliers
|
usd | ||
CY2022Q3 | SCTC |
Noncash Related To Increase In Property And Equipment Through A Decrease In Advances To Suppliers
NoncashRelatedToIncreaseInPropertyAndEquipmentThroughADecreaseInAdvancesToSuppliers
|
usd | |
SCTC |
Contract With Customer Asset Additions
ContractWithCustomerAssetAdditions
|
usd | ||
CY2021 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
usd | |
CY2021 | SCTC |
Contract With Customer Liability Revenue Recognized During Period Development Services
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriodDevelopmentServices
|
usd | |
CY2022Q3 | us-gaap |
Assets
Assets
|
19017000 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
23546000 | usd |
CY2022Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
366000 | usd |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
333-188920 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
SCOUTCAM INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
47-4257143 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
Suite 7A | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Industrial Park | ||
dei |
Entity Address Address Line3
EntityAddressAddressLine3
|
P.O. Box 3030 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Omer | ||
dei |
Entity Address Country
EntityAddressCountry
|
IL | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
8496500 | ||
dei |
City Area Code
CityAreaCode
|
+972 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
73 370-4691 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2022Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7121737 | shares |
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2586000 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8581000 | usd |
CY2022Q3 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
12579000 | usd |
CY2021Q4 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
11013000 | usd |
CY2022Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
15000 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
8000 | usd |
CY2022Q3 | us-gaap |
Inventory Gross
InventoryGross
|
652000 | usd |
CY2021Q4 | us-gaap |
Inventory Gross
InventoryGross
|
167000 | usd |
CY2022Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
272000 | usd |
CY2021Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
443000 | usd |
CY2022Q3 | us-gaap |
Assets Current
AssetsCurrent
|
16104000 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
20212000 | usd |
CY2022Q3 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
1555000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
1675000 | usd |
CY2022Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
708000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
781000 | usd |
CY2022Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
325000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
482000 | usd |
CY2022Q3 | SCTC |
Severance Pay Asset
SeverancePayAsset
|
325000 | usd |
CY2021Q4 | SCTC |
Severance Pay Asset
SeverancePayAsset
|
396000 | usd |
CY2022Q3 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
2913000 | usd |
CY2021Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
3334000 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
103000 | usd |
CY2022Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1429000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
346000 | usd |
CY2022Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
192000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
256000 | usd |
CY2022Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
352000 | usd |
CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
355000 | usd |
CY2022Q3 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
67000 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
39000 | usd |
CY2022Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
150000 | usd |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
210000 | usd |
CY2022Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2556000 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1309000 | usd |
CY2022Q3 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
2324000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
2074000 | usd |
CY2022Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
85000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
203000 | usd |
CY2022Q3 | SCTC |
Liability For Severance Pay
LiabilityForSeverancePay
|
324000 | usd |
CY2021Q4 | SCTC |
Liability For Severance Pay
LiabilityForSeverancePay
|
344000 | usd |
CY2022Q3 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
2733000 | usd |
CY2021Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
2621000 | usd |
CY2022Q3 | us-gaap |
Liabilities
Liabilities
|
5289000 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
3930000 | usd |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7121737 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7121737 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7121737 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7121737 | shares |
CY2022Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
7000 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
7000 | usd |
CY2022Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
36819000 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
34903000 | usd |
CY2022Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-23098000 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-15294000 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13728000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
19616000 | usd |
CY2022Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
19017000 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
23546000 | usd |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
506000 | usd | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
321000 | usd | |
CY2022Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
134000 | usd |
CY2021Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
23000 | usd |
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-183000 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
1279000 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
821000 | usd | |
CY2022Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
430000 | usd |
CY2021Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
211000 | usd |
us-gaap |
Gross Profit
GrossProfit
|
-773000 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
-500000 | usd | |
CY2022Q3 | us-gaap |
Gross Profit
GrossProfit
|
-296000 | usd |
CY2021Q3 | us-gaap |
Gross Profit
GrossProfit
|
-188000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3023000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1193000 | usd | |
CY2022Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1048000 | usd |
CY2021Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
550000 | usd |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
617000 | usd | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
629000 | usd | |
CY2022Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
171000 | usd |
CY2021Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
225000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3262000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3931000 | usd | |
CY2022Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
810000 | usd |
CY2021Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1603000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7675000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-6253000 | usd | |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2325000 | usd |
CY2021Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2566000 | usd |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
23000 | usd | |
us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
3000 | usd | |
CY2022Q3 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
8000 | usd |
CY2021Q3 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
3000 | usd |
SCTC |
Financing Income Expenses Net
FinancingIncomeExpensesNet
|
-152000 | usd | |
SCTC |
Financing Income Expenses Net
FinancingIncomeExpensesNet
|
-6000 | usd | |
CY2022Q3 | SCTC |
Financing Income Expenses Net
FinancingIncomeExpensesNet
|
73000 | usd |
CY2021Q3 | SCTC |
Financing Income Expenses Net
FinancingIncomeExpensesNet
|
1000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7804000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-6256000 | usd | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2244000 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2562000 | usd |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.10 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.05 | ||
CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.32 | |
CY2021Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.37 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7122000 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5968000 | shares | |
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7122000 | shares |
CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6930000 | shares |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
19616000 | usd |
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1916000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7804000 | usd | |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13728000 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15513000 | usd |
CY2022Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
459000 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2244000 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13728000 | usd |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3964000 | usd |
SCTC |
Stock Issued During Period Value Of Shares And Warrants
StockIssuedDuringPeriodValueOfSharesAndWarrants
|
19118000 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1317000 | usd | |
SCTC |
Exercise Of Warrants
ExerciseOfWarrants
|
2459000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-6256000 | usd | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
20602000 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
22482000 | usd |
CY2021Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
682000 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2562000 | usd |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
20602000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7804000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-6256000 | usd | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2244000 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2562000 | usd |
us-gaap |
Depreciation
Depreciation
|
160000 | usd | |
us-gaap |
Depreciation
Depreciation
|
63000 | usd | |
CY2022Q3 | us-gaap |
Depreciation
Depreciation
|
57000 | usd |
CY2021Q3 | us-gaap |
Depreciation
Depreciation
|
24000 | usd |
us-gaap |
Severance Costs1
SeveranceCosts1
|
51000 | usd | |
us-gaap |
Severance Costs1
SeveranceCosts1
|
-56000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1916000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1317000 | usd | |
CY2022Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
459000 | usd |
CY2021Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
682000 | usd |
SCTC |
Gain Or Loss On Exchange From Operating Lease Liability
GainOrLossOnExchangeFromOperatingLeaseLiability
|
52000 | usd | |
CY2022Q3 | SCTC |
Gain Or Loss On Exchange From Operating Lease Liability
GainOrLossOnExchangeFromOperatingLeaseLiability
|
2000 | usd |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-301000 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
12000 | usd | |
CY2022Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
26000 | usd |
CY2021Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
8000 | usd |
SCTC |
Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
|
66000 | usd | |
CY2022Q3 | SCTC |
Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
|
43000 | usd |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
7000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
2000 | usd | |
CY2022Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-84000 | usd |
CY2021Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-41000 | usd |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
485000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-99000 | usd | |
CY2022Q3 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
43000 | usd |
SCTC |
Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
|
210000 | usd | |
CY2022Q3 | SCTC |
Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
|
78000 | usd |
CY2022Q3 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-58000 | usd |
CY2021Q3 | SCTC |
Issuance Expenses
IssuanceExpenses
|
95000 | usd |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
2459000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
|
-28000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
|
-72000 | usd | |
CY2022Q3 | us-gaap |
Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
|
-45000 | usd |
CY2021Q3 | us-gaap |
Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
|
-12000 | usd |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-171000 | usd | |
us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
170000 | usd | |
CY2022Q3 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-138000 | usd |
CY2021Q3 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-339000 | usd |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
263000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
122000 | usd | |
CY2022Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
57000 | usd |
CY2021Q3 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-102000 | usd |
us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
-120000 | usd | |
us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
504000 | usd | |
CY2022Q3 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
-60000 | usd |
CY2021Q3 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
124000 | usd |
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
1333000 | usd | |
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
529000 | usd | |
CY2022Q3 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-102000 | usd |
CY2021Q3 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-8000 | usd |
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-3000 | usd | |
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
34000 | usd | |
CY2022Q3 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-24000 | usd |
CY2021Q3 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-26000 | usd |
us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-60000 | usd | |
us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
60000 | usd | |
CY2022Q3 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-145000 | usd |
CY2021Q3 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
82000 | usd |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4107000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4704000 | usd | |
CY2022Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1709000 | usd |
CY2021Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1650000 | usd |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
87000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
483000 | usd | |
CY2022Q3 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
45000 | usd |
CY2021Q3 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
313000 | usd |
SCTC |
Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
|
5000000 | usd | |
SCTC |
Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
|
6500000 | usd | |
CY2022Q3 | SCTC |
Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
|
3000000 | usd |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1587000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-483000 | usd | |
CY2022Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3045000 | usd |
CY2021Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-313000 | usd |
SCTC |
Issuance Expenses
IssuanceExpenses
|
50000 | usd | |
SCTC |
Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
|
19118000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-5694000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
16340000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
21527000 | usd | |
CY2021Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-95000 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-4754000 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-2058000 | usd |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-301000 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
12000 | usd | |
CY2022Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
26000 | usd |
CY2021Q3 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
8000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
8581000 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
3373000 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
7314000 | usd |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
21775000 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2586000 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
19725000 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2586000 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
19725000 | usd |
SCTC |
Non Cash Issuance Expenses
NonCashIssuanceExpenses
|
45000 | usd | |
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
118000 | usd | |
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
423000 | usd | |
CY2022Q3 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
37000 | usd |
CY2021Q3 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
64000 | usd |
SCTC |
Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
|
-65000 | usd | |
CY2022Q3 | SCTC |
Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
|
-65000 | usd |
SCTC |
Noncash Related To Increase In Property And Equipment Through A Decrease In Advances To Suppliers
NoncashRelatedToIncreaseInPropertyAndEquipmentThroughADecreaseInAdvancesToSuppliers
|
31000 | usd | |
CY2021Q3 | SCTC |
Noncash Related To Increase In Property And Equipment Through A Decrease In Advances To Suppliers
NoncashRelatedToIncreaseInPropertyAndEquipmentThroughADecreaseInAdvancesToSuppliers
|
31000 | usd |
us-gaap |
Nature Of Operations
NatureOfOperations
|
<p id="xdx_80C_eus-gaap--NatureOfOperations_znSBJ2HWFmV5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_829_zEXyK95L8Tli">GENERAL</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 49.6pt; text-align: justify; text-indent: -49.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ScoutCam Inc. (the “Company”), formerly known as Intellisense Solutions Inc., (“Intellisense”), was incorporated under the laws of the State of Nevada on March 22, 2013. Prior to the closing of the Exchange Agreement (as defined below), the Company was a non-operating “shell company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned subsidiary, ScoutCam Ltd. (“ScoutCam”), was formed in the State of Israel on January 3, 2019, as a wholly-owned subsidiary of Medigus Ltd. (“Medigus”), an Israeli company traded on the Nasdaq Capital Market, and commenced operations on March 1, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2019, Medigus and ScoutCam consummated an asset transfer agreement, under which Medigus transferred and assigned certain assets and intellectual property rights related to its miniaturized imaging business to ScoutCam.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 30, 2019, Intellisense and Medigus consummated a securities exchange agreement (the “Exchange Agreement”), pursuant to which Medigus delivered 100% of its holdings in ScoutCam to Intellisense in exchange for shares of Intellisense’s common stock representing 60% of the issued and outstanding share capital of Intellisense immediately upon the consummation of the Exchange Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022, Medigus beneficially owned 27.02% of the Company’s outstanding common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through ScoutCam, provides image-based platforms. Through the use of its proprietary visualization technology, ScoutCam offers solutions across predictive maintenance and condition-based monitoring markets, in sectors such as energy, automotive and aviation. ScoutCam’s solutions are based on small and highly resilient cameras, specialized AI analysis and supplementary technologies.</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCOUTCAM INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – GENERAL </b>(continued):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 60.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 9, 2021, the Company amended its Articles of Incorporation to effect a <span id="xdx_908_eus-gaap--StockholdersEquityReverseStockSplit_c20210808__20210809_zFoNTDEh2o44" title="Stockholders' equity, reverse stock split">nine-to-one</span> reverse stock split of its outstanding Common Stock. As a result of the reverse stock split, every nine shares of the Company’s outstanding Common Stock were combined and reclassified into one share of the Company’s Common Stock. No fractional shares were issued in connection with or following the reverse split. The amount of authorized capital of the Company’s Common Stock and par value of such shares remained unchanged. All share, stock option and per share information in these interim consolidated financial statements have been adjusted to reflect the reverse stock split on a retroactive basis.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since incorporation of the Company and through September 30, 2022, the Company accumulated a deficit of $<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20220930_zqM83CJWzp5" title="Accumulated deficit">23,098</span> thousand and its activities have been funded mainly by its shareholders. The Company’s management believes the Company’ cash and cash resources as of September 30, 2022 will enable the Company to fund its operating plan for more than 12 months from the date of issuance of these financial statements. The Company expects to continue to incur significant research and development expenses and other costs related to its ongoing operations and, as a result, will need to obtain additional funding in order to continue its future operations.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In early 2020, the World Health Organization declared the rapidly spreading coronavirus disease (COVID19) outbreak a pandemic. This pandemic has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. The Company considered the impact of COVID-19 on its operations and determined that there were no material adverse impacts on the Company’s results of operations and financial position as of September 30, 2022. These estimates may change, as new events occur, and additional information is obtained.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2021Q3 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
nine-to-one | |
CY2022Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-23098000 | usd |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P7Y | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0198 | pure | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84C_eus-gaap--UseOfEstimates_zsFSBWlZQhX6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c. </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zEklE462Pan3">Use of estimates</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCOUTCAM INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES </b>(continued):</span></p> | ||
CY2022Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
325000 | usd |
CY2022Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
277000 | usd |
us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
203000 | usd | |
us-gaap |
Sublease Income
SubleaseIncome
|
3000 | usd | |
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
203000 | usd | |
us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
203000 | usd | |
CY2022Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P0Y5M19D | |
CY2022Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.06 | pure |
CY2022Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
52000 | usd |
CY2022Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
194000 | usd |
CY2022Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
40000 | usd |
CY2022Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
6000 | usd |
CY2022Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
292000 | usd |
CY2022Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
15000 | usd |
CY2022Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
277000 | usd |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1253554 | shares |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
52569 | shares | |
CY2022Q3 | us-gaap |
Share Price
SharePrice
|
7.2 | |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
4.5 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.2762 | pure | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.31 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
53000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
4.50 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
3.17 | ||
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1253985 | shares |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.36 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
748531 | shares | |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
3.03 | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1916000 | usd | |
CY2022Q3 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
1555000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
1675000 | usd |
CY2022Q3 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
3753000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
2420000 | usd |
us-gaap |
Revenues
Revenues
|
222000 | usd | |
CY2021Q4 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
1675000 | usd |
CY2020Q4 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
1130000 | usd |
CY2021 | SCTC |
Contract With Customer Asset Additions
ContractWithCustomerAssetAdditions
|
545000 | usd |
us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
-120000 | usd | |
CY2022Q3 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
1555000 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
167000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
1675000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
2420000 | usd |
CY2020Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
848000 | usd |
SCTC |
Contract With Customer Liability Deferred Revenue Relating To New Sales
ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales
|
1616000 | usd | |
CY2021 | SCTC |
Contract With Customer Liability Deferred Revenue Relating To New Sales
ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales
|
1641000 | usd |
SCTC |
Contract With Customer Liability Revenue Recognized During Period Development Services
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriodDevelopmentServices
|
-211000 | usd | |
us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
-72000 | usd | |
CY2021 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
-69000 | usd |
CY2022Q3 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
3753000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
2420000 | usd |
CY2022Q3 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
3753000 | usd |
CY2022Q3 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
544000 | usd |
CY2021Q4 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
99000 | usd |
CY2022Q3 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
65000 | usd |
CY2021Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
2000 | usd |
CY2022Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
43000 | usd |
CY2021Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
66000 | usd |
CY2022Q3 | us-gaap |
Inventory Net
InventoryNet
|
652000 | usd |
us-gaap |
Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
|
87000 | usd | |
us-gaap |
Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
|
52000 | usd |